These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 2722344)
1. Hyperpigmentation of the nail from lead deposition. Zhu WY; Xia MY; Huang SD; Du D Int J Dermatol; 1989 May; 28(4):273-5. PubMed ID: 2722344 [No Abstract] [Full Text] [Related]
2. Nail and mucocutaneous hyperpigmentation with azidothymidine therapy. Greenberg RG; Berger TG J Am Acad Dermatol; 1990 Feb; 22(2 Pt 2):327-30. PubMed ID: 2303586 [TBL] [Abstract][Full Text] [Related]
3. [Nail hyperpigmentation as a secondary effect of doxorubicin]. Sanz Ortiz J; Méndez Batán MA; Fariñas Alvarez C; Gutiérrez del Río C Med Clin (Barc); 1982 Jun; 79(1):49-50. PubMed ID: 7121110 [No Abstract] [Full Text] [Related]
4. Nail hyperpigmentation secondary to therapy with doxorubicin. Giacobetti R; Esterly NB; Morgan ER Am J Dis Child; 1981 Apr; 135(4):317-8. PubMed ID: 7211789 [TBL] [Abstract][Full Text] [Related]
7. [Ungual hyperpigmentation as the only sign of bleomycin poisoning]. Veraldi S; Renzi D; Schianchi R; Sala F; Marini D G Ital Dermatol Venereol; 1987 Sep; 122(9):443-5. PubMed ID: 2445668 [No Abstract] [Full Text] [Related]
8. Nail pigmentation associated with zidovudine. Dupon M; Seniuta P; Ragnaud JM; Guillaume D; Lacut JY Scand J Infect Dis; 1989; 21(2):237-8. PubMed ID: 2727639 [No Abstract] [Full Text] [Related]
9. Doxorubicin and hyperpigmentation. Alagaratnam TT; Choi TK; Ong GB Aust N Z J Surg; 1982 Oct; 52(5):531-3. PubMed ID: 6959604 [No Abstract] [Full Text] [Related]
10. [Nail pigmentation caused by antimalarials]. Pigrau C; Buti M; Janesca J; González A Med Clin (Barc); 1983 Apr; 80(11):512. PubMed ID: 6865530 [No Abstract] [Full Text] [Related]
11. Nail pigmentation with daunorubicin therapy. deMarinis M; Hendricks A; Stoltzner G Ann Intern Med; 1978 Oct; 89(4):516-7. PubMed ID: 697234 [No Abstract] [Full Text] [Related]
12. Nail pigmentation associated with zidovudine. Groark SP; Hood AF; Nelson K J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):1032-3. PubMed ID: 2808821 [No Abstract] [Full Text] [Related]
13. Nail pigmentation due to oral 8-methoxypsoralen. Naik RP; Singh G Br J Dermatol; 1979 Feb; 100(2):229-30. PubMed ID: 427025 [No Abstract] [Full Text] [Related]
14. Mitoxantrone induced hyperpigmentation. Kumar L; Kochipillai V N Z Med J; 1990 Feb; 103(883):55. PubMed ID: 2304701 [No Abstract] [Full Text] [Related]
15. Development of nail pigmentation during zidovudine therapy. Anders KH; Abele DC J Am Acad Dermatol; 1989 Oct; 21(4 Pt 1):792-3. PubMed ID: 2808794 [No Abstract] [Full Text] [Related]
16. 8-methoxypsoralen-induced nail pigmentation. Naik RP; Parameswara YR Int J Dermatol; 1982 Jun; 21(5):275-6. PubMed ID: 7095959 [No Abstract] [Full Text] [Related]
17. Cyclophosphamide nail pigmentation. Adam BA Singapore Med J; 1981 Feb; 22(1):35-7. PubMed ID: 7017940 [No Abstract] [Full Text] [Related]
18. Cyclophosphamide-induced nail pigmentation. Srikant M; Van Veen J; Raithatha A; Reilly JT Br J Haematol; 2002 Apr; 117(1):2. PubMed ID: 11918527 [No Abstract] [Full Text] [Related]
19. Zidovudine-induced nail pigmentation. Azon-Masoliver A; Mallolas J; Gatell J; Castel T Arch Dermatol; 1988 Oct; 124(10):1570-1. PubMed ID: 3262330 [No Abstract] [Full Text] [Related]